 |
| |
 |
| |
 |
| |
 |
| |
 |
| _____________________________________________________________________________________________________________________ © 2005-11 All Rights Reserved. NOD Pharmaceuticals, Inc. |
SAN DIEGO, August 20, 2005 /For Immediate Release/ -- NOD Pharmaceuticals, Inc. today
Medical Science & Technology Co., Ltd., is registered in Zhangjiang Hi-Park in Shanghai, a premier
biotech cluster in China.
Biolaxy (www.biolaxy.com) is developing the leading product candidates, oral insulin and oral
interferon, based on the nano-particle oral delivery or NOD technology from NOD Pharmaceuticals.
"China offers advantages such as low cost and short development cycle, so we expect to prove our
technology and launch our products at a fraction of cost and time of what you expect otherwise for
the US market," William Lee, CEO of NOD Pharmaceuticals, Inc., explains.
NOD Pharmaceuticals is a biopharmaceutical company focusing on innovative drug delivery.
SOURCE NOD Pharmaceuticals, Inc.
William Lee, Ph.D, CEO of NOD Pharmaceuticals, Inc., +1-858-457-0899
URL http://www.nodpharm.com
Email info@nodpharm.com
Medical Science & Technology Co., Ltd., is registered in Zhangjiang Hi-Park in Shanghai, a premier
biotech cluster in China.
Biolaxy (www.biolaxy.com) is developing the leading product candidates, oral insulin and oral
interferon, based on the nano-particle oral delivery or NOD technology from NOD Pharmaceuticals.
"China offers advantages such as low cost and short development cycle, so we expect to prove our
technology and launch our products at a fraction of cost and time of what you expect otherwise for
the US market," William Lee, CEO of NOD Pharmaceuticals, Inc., explains.
NOD Pharmaceuticals is a biopharmaceutical company focusing on innovative drug delivery.
SOURCE NOD Pharmaceuticals, Inc.
William Lee, Ph.D, CEO of NOD Pharmaceuticals, Inc., +1-858-457-0899
URL http://www.nodpharm.com
Email info@nodpharm.com
| China Subsidiary of NOD Pharmaceuticals Is in Operation |
 |  |  |
-Innovation Delivered